Atherosclerosis in psoriatic arthritis.

Area of Science:

• Immunology
• Rheumatology
• Cardiovascular Medicine

Background:

• Autoimmune rheumatic diseases accelerate atherosclerosis.
• Immune cells and inflammatory cytokines are present in atherosclerotic lesions.
• Psoriatic arthritis (PsA) is linked to obesity, diabetes, dyslipidemia, hypertension, and increased cardiovascular risk.

Purpose of the Study:

• To explore the role of immune factors in accelerated atherosclerosis in PsA.
• To identify specific immunological contributors to cardiovascular burden in PsA patients.

Main Methods:

• Review of scientific literature on PsA, atherosclerosis, and immunology.
• Analysis of the interplay between PsA pathogenesis and cardiovascular disease mechanisms.

Main Results:

• PsA patients exhibit accelerated atherosclerosis and higher cardiovascular morbidity/mortality.
• Both disease-specific and traditional risk factors contribute to atherosclerotic burden in PsA.
• Immune factors implicated in PsA, such as C-reactive protein (CRP), TNF-α, IFN-γ, IL-1, IL-6, IL-23, and Th17 cells, are also involved in atherogenesis.

Conclusions:

• The immune dysregulation in PsA significantly contributes to accelerated atherosclerosis.
• Targeting specific inflammatory pathways in PsA may mitigate cardiovascular risk.